Introduction {#section1-2192568217747572}
============

The United States has seen a growing rate of allogeneic blood transfusion in the context of spine surgery.^[@bibr1-2192568217747572],[@bibr2-2192568217747572]^ Intraoperative blood loss necessitates the transfusion of allogeneic blood to avoid perioperative anemia, itself identified as an independent risk factor in perioperative morbidity and mortality.^[@bibr3-2192568217747572],[@bibr4-2192568217747572]^ However, there exist consequential trade-offs between the risks and benefits of allogeneic blood transfusion versus anemia in terms of their effects on perioperative outcomes.^[@bibr3-2192568217747572],[@bibr4-2192568217747572]^

Although the adverse effects of allogeneic blood transfusion on postoperative infection in the context of spine surgery have been demonstrated, the low power and uncontrolled potential confounds of many of these studies has limited the interpretation of their data. The aim of this systematic review is to evaluate the association between allogeneic transfusion and postoperative infection in spine surgery patients, as well as the many modifying risk factors. We sought to answer the following key questions: (1) Does allogeneic blood transfusion increased the risk of postoperative infection in patients undergoing spine surgery compared with no blood transfusion? (2) Are there any factors that modify the risk of infection associated with allogeneic blood transfusion?

Materials and Methods {#section2-2192568217747572}
=====================

Study Design: Systematic Review {#section3-2192568217747572}
-------------------------------

### Information Sources and Search {#section4-2192568217747572}

PubMed, Cochrane Central Register of Controlled Trials, and reference lists from included studies were searched from inception to April 20, 2017. Search strategy can be found in the Supplemental Online Material.

### Eligibility Criteria {#section5-2192568217747572}

#### Inclusion criteria {#section6-2192568217747572}

\(1\) Adult patients receiving surgery for degenerative spine disease and (2) comparative studies comparing the risk of infection in those with allogeneic blood transfusion versus no blood transfusion.

#### Exclusion criteria {#section7-2192568217747572}

\(1\) More than or equal to 20% of patients who received spine surgery for trauma or cancer, (2) ≥20% of patients who received autologous blood instead of allogeneic blood, (3) outcomes other than infection, and (4) case series.

### Data Identification and Extraction {#section8-2192568217747572}

Articles were selected for inclusion and data was extracted by 2 investigators (CF, JRD). Discrepancies were resolved through discussion. The following data items were recorded: study author, study design, study demographics (sample size, age, sex), data source, spine segment treated, timing of transfusion, covariates analyzed, odds ratio from both univariate and multivariate models comparing infection in those receiving blood transfusion versus no transfusion.

### Outcomes {#section9-2192568217747572}

Surgical site infection, urinary tract infection, respiratory tract infection, sepsis.

Analysis and Synthesis of Results {#section10-2192568217747572}
---------------------------------

Qualitative synthesis and meta-analysis. Because of the likelihood of confounding, the primary analysis used adjusted versus crude odds ratios. For meta-analysis, we performed a logarithmic transformation of the adjusted odds ratios and confidence intervals. The corresponding standard errors were then computed. Next the studies were pooled and weighted according to the inverse of their respective variances, which were derived from the standard errors. A random effects model was assumed. Final values were exponentiated back to and presented in their original scale. Calculations and figures were done with RevMan v. 5.2.

Results {#section11-2192568217747572}
=======

Study Selection and Characteristics {#section12-2192568217747572}
-----------------------------------

We identified 19 of 88 studies as potentially meeting inclusion criteria. After full-text review of the 19 studies, 8 were excluded (wrong population, n = 3; wrong comparison, n=2; wrong study design, n = 2; and wrong outcome, n = 1) ([Figure 1](#fig1-2192568217747572){ref-type="fig"}). Citations and a comprehensive list of reasons for exclusion can be found in the Supplemental Online Material. The remaining 11 met inclusion criteria and were retained. These studies involved 8428 patients who received a transfusion and 43 242 who did not. They are composed of 6 retrospective cohort studies^[@bibr5-2192568217747572][@bibr6-2192568217747572][@bibr7-2192568217747572][@bibr8-2192568217747572][@bibr9-2192568217747572]--[@bibr10-2192568217747572]^ and 5 retrospective case-control studies.^[@bibr11-2192568217747572][@bibr12-2192568217747572][@bibr13-2192568217747572][@bibr14-2192568217747572]--[@bibr15-2192568217747572]^ All studies have moderately high or high risk of bias, class of evidence (CoE) III or IV (see Supplemental Online Material for CoE evaluation). Characteristics of the included studies are summarized in [Table 1](#table1-2192568217747572){ref-type="table"}.

![Study selection.](10.1177_2192568217747572-fig1){#fig1-2192568217747572}

###### 

Study Characteristics.

![](10.1177_2192568217747572-table1)

  First Author (Year), Design                                                            Population                                                                                     Data Source                                                                                                                                                               Timing of transfusion                                     Surgery                                                                                                                        Infection outcomes                                                                               Covariates                                                                                                                                                                         Results, OR (95% CI)                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  -------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Aoude (2016), retrospective cohort Level of evidence: III                              N = 13 695 Age: 59.6 years (± 13.5) Male: 44% Transfusion N = 2407 No transfusion N = 11 288   American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database 2010-2013                                                                 Timing: Intraoperative, and postoperative                 Lumbar (n =13 170) and thoracic (n = 525) with or without interbody fusion Approach: anterior, posterior, and posterolateral   Superficial, deep, or organ/space SSI as defined by CDC F/U: ≤30 days                            AgeGenderRaceBMISmokingDiabetesDyspneaCOPDCHFDialysisSteroidsASA classHypertensionIn/outpatient                                                                                    Functional status prior surgeryMultilevel surgeryOperation timeElective surgeryReturn to operating roomPreoperative hematocritPreoperative platelet countPreoperative WBCPreoperative serum creatininePreoperative BUNPreoperative serum sodiumBleeding diseaseLength of surgery                                                                                                                                                                                         *SSI lumbar spine:* Deep infection aOR 2.44 (1.55-3.83) Superficial infection aOR 1.52 (1.03-2.26) *SSI thoracic spine:* Deep infection aOR 0.56 (0.11-3.01) Superficial infection aOR 0.94 (0.31-2.81)
  Apisarnthanarak (2003), retrospective matched case-control Level of evidence: IV       N = 60 Age: 57.7 years (24-85) Male: 47% Cases: n = 13 Controls: n = 47                        Community hospital (St Louis, Missouri) January 1, 1998 to June 30, 2000                                                                                                  Timing: Intraoperative and postoperative                  Laminectomy, spinal fusion, or both Approach: unknown                                                                          Superficial, deep, or organ/space SSI as defined by CDC F/U: ≤30 days                            AgeGenderRaceBMIMalnutritionDural tearC-armPropofolIrrigationAmbulationClotting agentsCorticosteroidsSurgery levelDiabetesSmokingIncontinenceGlucose levelASA classTumor removal   Skin preparation techniquesHypothermia during surgeryProcedure typeProcedure durationInstrumentation for fusionAllograft/autograftGlue to cement dural patchUse of operating microscopeDrain use & typeSurgical personnelNumber/type of transfusionsNo. days in ICUBathing/showering in hospitalDischarge to rehabilitationProphylactic antibioticsProphylactic antibioticsHospitalization durationUnderlying malignancySpinal cord compressionPrevious spinal surgery   *SSI:* OR^a^ = 1.33 (0.32-5.55)
  Fisahn (2017), retrospective cohort Level of evidence: III                             N = 56 Age: 65.4 years (±12.4) Male: 35.7% No transfusion n = 20 Transfusion n = 36            Swedish Medical Center, Seattle, WA 2012-2015                                                                                                                             Timing: Perioperative                                     Spine fusion of at least 8 levels Approach: posterior                                                                          Any infection (UTI, wound infection, pneumonia, *Clostridium difficile,* sepsis) F/U: ≤90 days   AgeSmokerGenderBMIDiabetesSteroid useLevel of surgeryDrain usage                                                                                                                   Vancomycin powder (2 mg topical application)Intraoperative shockOther interventions/outcomesStarting/ending hematocritEstimated blood lossTransfused unitsLength of surgery                                                                                                                                                                                                                                                                                              *SSI:* OR, aOR not calculable *Any infection:* OR = 5.09 (0.93-50.85) aOR = 3.5 (0.58-20.9)
  Janssen (2015), retrospective cohort Level of evidence: III                            N = 3721 Age: 55 years (16) Male: 53% Transfusion n = 293 No transfusion n = 3428              Massachusetts General Hospital Research Patient Data Registry 2001-2013                                                                                                   Timing: 7 days prior up to 30 days after operation        Laminectomy and/or arthrodesis of lumbar spine Approach: anterior, posterior                                                   SSIRTIEndocarditisMeningitisUTICentral venous line F/U: ≤90 days                                 AgeGenderRaceBMIComorbiditiesTobacco useObesityCHF                                                                                                                                 HemoglobinOperative treatmentRenal diseaseDuration of surgerySingle vs multilevelAnterior/posterior approachYear of surgeryChronic pulmonary diseaseChronic diabetes                                                                                                                                                                                                                                                                                                     *SSI:* aOR 2.6 (1.3-5.3) *Any infection:* aOR 2.6 (1.7-3.9) *UTI:* aOR 2.2 (1.3-3.9) *Pneumonia* aOR 2.3 (0.96-5.3)
  Kato (2016),^b^ retrospective propensity-matched cohort study Level of evidence: III   N = 8550 Age ≥70 years: 70.4% Male: 63% No transfusion n = 4275 Transfusion n = 4275           Japanese Diagnosis Procedure Combination database (includes 82 academic hospitals) July 1 to December 31 each year 2007-2010 January 1, 2011 to March 31, 2012            Timing: Perioperative                                     Laminectomy, laminoplasty and/or fusion surgery of the lumbar spine Approach: unknown                                          SSIRTIUTISepsisF/U: NR                                                                           GenderAgeDiagnosesLength of stayDiabetesHemodialysisCell saver use                                                                                                                 Volume transfusedCardiovascular diseaseCerebrovascular diseaseDecompression or fusionDuration of anesthesiaType of hospital                                                                                                                                                                                                                                                                                                                                              *SSI:* OR 2.87 (2.47-3.33) aOR 1.88 (1.40-2.50) *RTI:* OR 2.55 (1.94-3.32) aOR 1.12 (0.74-1.69) *UTI:* OR 3.07 (2.32-4.02) aOR 2.52 (1.50-4.24) **[Sepsis:]{.ul}** OR 0.87 (0.79-0.91) aOR 3.01 (0.97-9.33)
  Maragakis (2009), retrospective case-control Level of evidence: IV                     N = 208 Age: 55 years (19-88) Male: 49% Cases: n = 104 Controls: n = 104                       Johns Hopkins Hospital 2001-2004                                                                                                                                          Timing: preoperative, intraoperative, and postoperative   Laminectomy and/or fusion of lumbar spine Approach: various                                                                    Superficial, deep, or organ/space SSI as defined by CDC F/U: ≤30 days                            AgeGenderSmokingDiabetesCardiac diseaseObesityASA scoreKarnofsky scoreFiO~2~ \<50%Dural tearInstrumentationCSF leak                                                                Emergent/urgent surgeryRazor shaving before surgeryAntimicrobial prophylaxisIntraoperative nitrous oxidePerioperative glucose \>126 mg/dLLowest intraoperative temperatureIntraoperative infusion rateProcedure durationLumbar-sacral level of surgeryPosterior surgical approachPrevious spinal surgeryEuropean descent                                                                                                                                                 *SSI:* OR: 6.7 (3.6-13.0) aOR for covariates: NS
  Olsen (2003), retrospective case-control Level of evidence: IV                         N = 219 Male: 59.4% Cases: n = 41 Controls: n = 178                                            Barnes-Jewish Hospital, Washington University School of Medicine, 1996-1999                                                                                               Timing: Intraoperative and postoperative                  Cervical, lumbar, thoracic, lumbosacral, multiple level laminectomy and/or fusion Approach: anterior, posterior, and other     Superficial, deep, or organ/space SSI as defined by CDC F/U: NS                                  AgeGenderRaceBMISmokingDiabetesPrior spinal opIncontinenceASA classSteroidsParalysisSkin antisepsisLevel of opMicroscopeDural tear                                                 Spinal cord compressionChemotherapy or irradiationRecent injury/traumaPreoperative hospitalizationRazor shaving vs clippingProphylactic antibioticsLaminectomy vs fusionAllograft vs autograftInstrumentationResection of tumorOther current opsIntraoperative hypothermiaPostoperative CSF leakDuration of procedureIntraoperative drugs                                                                                                                                *SSI:* Unadjusted OR: 5.6 (2.6-12.2) aOR for covariates: NR
  Olsen (2008), retrospective case-control Level of evidence: IV                         N = 273^c^ Age: 52.4 years (15.2-94.4) Male: 47.6% Cases: n = 36 Controls: n = 192             Barnes-Jewish Hospital, Washington University School of Medicine, 1998-2002                                                                                               Timing: Perioperative                                     Laminectomy, discectomy and/or arthrodesis of the spine Approach: unknown                                                      Superficial, deep, or organ/space SSI as defined by CDC F/U: 1 year                              BMIDiabetesDiagnosisASA classIV steroidsCervical levelDrains                                                                                                                       Posterior approachProphylactic antibioticsNumber of vertebral levelsDuration of procedureNerve root compressionResident surgeonsPostoperative incontinencePre- or postoperative incontinence                                                                                                                                                                                                                                                                             *SSI:* Unadjusted OR: 3.4 (1.6-7.4) aOR for covariates: NR
  Triulzi (1992), retrospective cohort Level of evidence: III                            N = 49^d^ Age 32.2 years Male: 46% Transfusion n = 24 No transfusion n = 25                    Department of Pathology and Laboratory Medicine, Transfusion Medicine and Laboratory Hematology Units, University of Rochester Medical Center November 1988 to May 1990   Timing: Unknown                                           Spinal fusion procedures Approach: anterior, posterior                                                                         In-hospital infections F/U: in-hospital                                                          AgeGenderDiagnosisBlood lossSurgeonWBC countWBC differentialCulture results                                                                                                        Length of hospitalizationKind and amount of transfusionsKind and amount of blood lossTransfusion historyDays of fever ≥38° cDays on antibioticsDuration of surgerySurgical procedureAdmission HctsPostoperative day 7 Hcts                                                                                                                                                                                                                                               *In-hospital:* Results, OR (95% Cls) *Infections:* OR^e^ 6.32 (0.61-310.8)
  Veeravegu (2009), retrospective cohort Level of evidence: III                          N = 24 774 Age \<60 years: 66% Male: 95% No transfusion n = 23 629 Transfusion n = 1143        Veterans Affairs' NSQIP database 1997-2006                                                                                                                                Timing: Intraoperative                                    Spinal decompression, fusion, or instrumentation Approach: unknown                                                             Superficial and deep wound infection F/U: ≤30 days                                               AgeGenderRaceWeight lossDiabetesAlcohol useHctWBCCreatineSmoker                                                                                                                    Fusion or instrumentationOperative durationDisseminated cancerASA classPreoperative sepsisEmergencyBleeding disorderSteroid useFunctional status                                                                                                                                                                                                                                                                                                                         *SSI:* OR = 2.13 (1.62-2.75) aOR = 1.42 (1.07-1.90)
  Woods (2013), retrospective matched case-control Level of evidence: IV                 N = 147 Age: 61 years (23-83) Male: 49% Cases: n = 56 Controls: n = 91                         University of Pittsburgh Medical Center 2005-2009                                                                                                                         Timing: Intraoperative and postoperative                  Lumbar laminectomy and instrumented fusion (88%) Approach: anterior and posterior                                              Superficial, deep, or organ/space SSI as defined by CDC (spinal or iliac crest) F/U: ≤30 days    AgeGenderBMISmokingDiabetesIBCG                                                                                                                                                    Preoperative hemoglobinVolume of intraoperative blood lossRevision procedureBMP-2 and allograftCharlson ComorbidityLength of surgery                                                                                                                                                                                                                                                                                                                                     *SSI:* aOR 1.25 (0.55-2.97) Transfusion volume associated with SSI aOR 4.00 (1.96-8.15)

Abbreviations: aOR, adjusted odds ratio; ASA, American Society of Anesthesiologists; BMI, body mass index; BUN, blood urea nitrogen; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CSF, cerebrospinal fluid; FiO~2~, fraction of inspired oxygen; Hcts, hematocrit; NR, not reported; OR, unadjusted or crude odds ratio; RTI, respiratory tract infection; SSI, surgical site infection; CDC, Centers for Disease Control and Prevention; WBC, white blood cell.

^a^ Calculated from Apisarnthanarak et al,^[@bibr11-2192568217747572]^ [table 2](#table2-2192568217747572){ref-type="table"}.

^b^ Demographic information and unadjusted OR based on cohort of 79 361 patients without transfusion and 5,289 with transfusion. aOR based on propensity matched cohort

^c^ Demographic information based on cohort that included a group receiving autologous blood transfusion. However, the ORs for Olsen 2008 are for allogeneic blood only (cases: n = 15, controls: n = 33) compared with no transfusion (cases: n = 21, controls: n = 159).

^d^ Population characteristics given for 102 patients comprised of 3 arms; allogeneic arm (n=24), autologous blood (n=60) and no transfusion (n=25). The total, N=109, represents the number of surgeries as 7 patients had a subsequent operation.

^e^ Calculated from Triulzi et al,^[@bibr9-2192568217747572]^ [figure 1](#fig1-2192568217747572){ref-type="fig"}.

Does allogeneic blood transfusion increase the risk of postoperative infection in patients undergoing spine surgery compared with no blood transfusion?

### Surgical Site Infection {#section13-2192568217747572}

With regard to surgical site infection (SSI), results from 10 low-quality studies are mixed; 3 studies report a significant association between allogeneic blood transfusion and infection,^[@bibr7-2192568217747572],[@bibr8-2192568217747572],[@bibr10-2192568217747572]^ 4 report no significant association,^[@bibr12-2192568217747572][@bibr13-2192568217747572][@bibr14-2192568217747572]--[@bibr15-2192568217747572]^ 1 study describes an association within certain patient subgroups but not in others^[@bibr5-2192568217747572]^ and 2 do not report multivarariate analysis^[@bibr6-2192568217747572],[@bibr11-2192568217747572]^ ([Table 2](#table2-2192568217747572){ref-type="table"}).

###### 

Association (Crude and Adjusted Odds Ratio and 95% Confidence Interval) Between Allogeneic Blood Transfusion and Infection in Spine Surgery (*P* Value for Adjusted Odds Ratio Only).

![](10.1177_2192568217747572-table2)

  First Author           Transfusion Timing   Surgery           Infection     Crude OR (95% CI)   Adjusted OR (95% CI)   *P*
  ---------------------- -------------------- ----------------- ------------- ------------------- ---------------------- --------
  Janssen 2015           Periop               L +/−             SSI           ---                 2.6 (1.3-5.3)          .007
  Kato 2016              Periop               L +/−             SSI           2.9 (2.5-3.3)       1.9 (1.4-2.5)          \<.001
  Fisahn 2017            Periop               Sp +              SSI           Not calculable      Not calculable         
  Woods 2013             Intra, postop        L +/−             SSI           ---                 1.3 (0.5-2.9)          .37
  Olsen 08               Periop               Sp +/−            SSI           3.4 (1.6-7.3)       ns                     \>.05
  Apisarnthanarak 2003   Intra, postop        Sp +/−            SSI           1.3 (0.3-5.5)       ---                    
  Maragakis 2009         Periop               Sp +/−            SSI           6.7 (3.5-12.7)      ns                     \>.05
  Olsen 2003             Intra, postop        C, L, T, LS +/−   SSI           5.6 (2.6-12.1)      ns                     \>.05
  Veeravegu 2009         Intraop              Sp +/−            SSI           2.1 (1.6-2.8)       1.4 (1.1-1.9)          \<.05
  Aoude 2016                                                                                                             
   Deep                  Intra, postop        L +/−             SSI           2.8 (1.8-4.4)       2.4 (1.6-3.8)          \<.001
   Superficial           Intra, postop        L +/−             SSI           1.5 (1.0-2.3)       1.5 (1.03-2.3)         \<.037
   Deep                  Intra, postop        T +/−             SSI           0.5 (0.1-2.7)       0.6 (0.1-3.0)          .495
   Superficial           Intra, postop        T +/−             SSI           1.2 (0.4-3.5)       0.9 (0.3-2.8)          .914
  Janssen 2015           Periop               L +/−             Any           ---                 2.6 (1.7-3.9)          \<.001
  Fisahn 2017            Periop               Sp +              Any           5.1 (0.9-50.1)      3.5 (0.6-20.9)         .172
  Janssen 2015           Periop               L +/−             UTI           ---                 2.2 (1.3-3.8)          .004
  Kato 2016              Periop               L +/−             UTI           ---                 2.5 (1.5-4.2)          \<.001
  Triulzi 1992           Unknown              Sp +              In hospital   6.3 (0.6-310)       ---                    

Abbreviations: C, cervical; L, lumbar; LS, lumbosacral; ns, not significant (adjusted OR not reported); OR, odds ratio; T, thoracic; Sp, spinal; SSI, surgical site infection; UTI, urinary tract infection. +, with fusion; +/−, with or without fusion.

### Urinary Tract Infection {#section14-2192568217747572}

Two low-quality studies^[@bibr7-2192568217747572],[@bibr8-2192568217747572]^ found a significant association between allogeneic transfusion and urinary tract infection (UTI), pooled odds ratio 2.4 (95% CI, 1.6-3.5) ([Figure 2](#fig2-2192568217747572){ref-type="fig"}).

![The association of allogeneic blood transfusion and urinary tract infection in spine surgery.](10.1177_2192568217747572-fig2){#fig2-2192568217747572}

### Respiratory Tract Infection {#section15-2192568217747572}

Two low quality studies^[@bibr7-2192568217747572],[@bibr8-2192568217747572]^ failed to find an association between allogeneic transfusion and respiratory tract infection (RTI), pooled odds ratio 1.5 (95% CI, 1.7-2.9) ([Figure 3](#fig3-2192568217747572){ref-type="fig"}).

![The association of allogeneic blood transfusion and respiratory tract infection.](10.1177_2192568217747572-fig3){#fig3-2192568217747572}

### Any Infection {#section16-2192568217747572}

Two low-quality studies assessed the association between allogeneic blood transfusion and any infection. Any infection is defined as an SSI, RTI, UTI, sepsis, and *Clostridium difficile* in one study by Fisahn et al,^[@bibr6-2192568217747572]^ and SSI, RTI, UTI, endocarditis, meningitis, and central venous line infection in a second study by Janssen et al.^[@bibr7-2192568217747572]^ Pooling the studies result in a significant association, pooled odds ratio 2.6 (95% CI, 1.8-4.0) ([Figure 4](#fig4-2192568217747572){ref-type="fig"}).

![The association of allogeneic blood transfusion and any infection in spine surgery.](10.1177_2192568217747572-fig4){#fig4-2192568217747572}

### In-Hospital Infection {#section17-2192568217747572}

One small low-quality study did not find an association between allogeneic blood transfusion and in-hospital infection, crude odds ratio, 6.3 (95% CI, 0.6-310).

Are There Any Factors That Modify the Risk of Infection Associated With Allogeneic Blood Transfusion? {#section18-2192568217747572}
-----------------------------------------------------------------------------------------------------

One study stratified SSI results by spine segment, lumbar and thoracic. There was no statistical difference between the subgroups, *P* = .10, possibly due to the small sample size and variability in the thoracic spine ([Figure 5](#fig5-2192568217747572){ref-type="fig"}). Stratifying the results of all studies reporting SSI by spinal segment reveals that allogeneic blood transfusion is significantly associated with SSI in 3 of 4 studies in surgeries restricted to the lumbar spine. This is in contrast to only 1 of 5 studies reporting a significant association in studies of only the thoracic spine or in studies that likely include several segments ([Table 3](#table3-2192568217747572){ref-type="table"}). The pattern is similar for UTI and any infection.

![Subgroup analysis comparing the association of allogeneic blood transfusion and surgical site infection (SSI) between spine surgery of the lumbar and thoracic spines.](10.1177_2192568217747572-fig5){#fig5-2192568217747572}

###### 

Association (Adjusted Odds Ratio and 95% Confidence Interval) Between Allogeneic Blood Transfusion and Infection in Spine Surgery Stratified by Surgery Segment.

![](10.1177_2192568217747572-table3)

  First Author      Surgery Segment   Adjusted OR (95% CI)   *P*
  ----------------- ----------------- ---------------------- --------
  SSI                                                        
   Aoude 2016                                                
    Deep            Lumbar only       2.4 (1.6-3.8)          \<.001
    Superficial     Lumbar only       1.5 (1.03-2.3)         \<.037
   Janssen 2016     Lumbar only       2.6 (1.3 to 5.3)       .007
   Kato 2016        Lumbar only       1.9 (1.4-2.5)          \<.001
   Woods 2013       Lumbar only       1.3 (0.5-2.9)          .37
   Aoude 2016                                                
    Deep            Thoracic only     0.6 (0.1-3.0)          .495
    Superficial     Thoracic only     0.9 (0.3-2.8)          .914
   Olsen 2008       Spinal            Nonsignificant         \>.05
   Maragakis 2009   Spinal            Nonsignificant         \>.05
   Olsen 2003       Spinal            Nonsignificant         \>.05
   Fisahn 2017      Spinal            Not calculable         \--
   Veeravegu 2009   Spinal            1.4 (1.1-1.9)          \<.05
  UTI                                                        
   Janssen 2015     Lumbar only       2.2 (1.3-3.8)          .004
   Kato 2016        Lumbar only       2.5 (1.5-4.2)          \<.001
  RTI                                                        
   Janssen 2015     Lumbar only       2.3 (0.96-5.3)         \>.05
   Kato 2016        Lumbar only       1.1 (0.74-1.7)         \>.05
  Any infection                                              
   Janssen 2015     Lumbar only       2.6 (1.7-3.9)          \<.001
   Fisahn 2017      Spinal            3.5 (0.6-20.9)         .172

Evidence Summary ([Table 4](#table4-2192568217747572){ref-type="table"}) {#section19-2192568217747572}
========================================================================

-   Mixed results as to whether allogeneic blood transfusion is associated with SSI in spine surgery patients, strength of evidence *very low*.

-   Allogeneic blood transfusion is associated with UTI; pooled odds ratio 2.4 (95% CI, 1.6-3.5), strength of evidence *low*.

-   No association between allogeneic blood transfusion and RTI; pooled odds ratio 1.5 (95% CI, 0.7-2.9), strength of evidence *very low*.

-   Allogeneic blood transfusion is associated with any infection; pooled odds ratio 2.6 (95% CI, 1.8-4.0), strength of evidence *very low*.

-   Allogeneic blood transfusion was not significantly associated with SSI in a direct comparison when the surgery was performed in the lumbar spine compared with thoracic spine, strength of evidence *very low*.

###### 

Evidence Summary Table.

![](10.1177_2192568217747572-table4)

  Outcome                                                                                                                                                                    Follow-up                               Studies N                                                                                                                                                                                                                                                                                                    Serious Risk of Bias                                                                                                                                                                                                                                                                                         Serious Inconsistency   Serious Indirectness    Serious Imprecision    Conclusions                                Quality                                                                                                                                                                                                                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------- ----------------------- ---------------------- ------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------
  Key Question 1. Does allogeneic blood transfusion increased the risk of postoperative infection in patients undergoing spine surgery compared with no blood transfusion?                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Surgical site infection                                                                                                                                                    Variable, mostly within 30 to 90 days   10 observational studies^[@bibr5-2192568217747572][@bibr6-2192568217747572][@bibr7-2192568217747572]--[@bibr8-2192568217747572],[@bibr10-2192568217747572][@bibr11-2192568217747572][@bibr12-2192568217747572][@bibr13-2192568217747572][@bibr14-2192568217747572]--[@bibr15-2192568217747572]^ N = 51 430   Yes (−1)                                                                                                                                                                                                                                                                                                     Yes (−1)                No                      No                     Mixed results, pooled ORs not calculable   Very low                                                                                                                                                                                                                      
  Urinary tract infection                                                                                                                                                    Variable, ≤ 90 days and unreported      2 observational studies^[@bibr5-2192568217747572],[@bibr6-2192568217747572]^ N = 12 271                                                                                                                                                                                                                      No                                                                                                                                                                                                                                                                                                           No                      No                      No                     Pooled aOR: 2.4 (95% CI, 1.6-3.5)          Low                                                                                                                                                                                                                           
  Respiratory tract infection                                                                                                                                                Variable, ≤90 days and unreported       2 observational studies^[@bibr5-2192568217747572],[@bibr6-2192568217747572]^ N = 12 271                                                                                                                                                                                                                      No                                                                                                                                                                                                                                                                                                           Yes (−1)                No                      No                     Pooled aOR: 1.5 (95% CI, 0.7-2.9)          Very low                                                                                                                                                                                                                      
  Any infection                                                                                                                                                              ≤ 90 days                               2 observational studies^[@bibr5-2192568217747572],[@bibr10-2192568217747572]^ N = 3 777                                                                                                                                                                                                                      Yes (-1)                                                                                                                                                                                                                                                                                                     Yes (−1)                No                      No                     Pooled aOR: 2.6 (95% CI, 1.8-4.0)          Very low                                                                                                                                                                                                                      
  Subgroup                                                                                                                                                                   Outcome                                 Follow-up                                                                                                                                                                                                                                                                                                    Studies N                                                                                                                                                                                                                                                                                                    Serious Risk of Bias    Serious Inconsistency   Serious Indirectness   Serious Imprecision                        Conclusions                                                                                                                                                                                                                   Quality
  Key Question 2, Are there any factors that modify the risk of infection?                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Spine segment, lumbar vs thoracic or spinal                                                                                                                                Surgical site infection                 Variable, mostly within 30 to 90 days                                                                                                                                                                                                                                                                        10 observational studies^[@bibr5-2192568217747572][@bibr6-2192568217747572][@bibr7-2192568217747572]--[@bibr8-2192568217747572],[@bibr10-2192568217747572][@bibr11-2192568217747572][@bibr12-2192568217747572][@bibr13-2192568217747572][@bibr14-2192568217747572]--[@bibr15-2192568217747572]^ N = 51 430   Yes (−1)                No                      No                     No                                         No significant association in 1 study stratifying on spine segment Lumbar---aOR: 1.9 (95% CI, 1.2-3.0) Thoracic---aOR (95% CI 0.3-2.0) Test for heterogeneity across subgroups for all other studies could not be performed   Very low

Clinical Guidelines {#section20-2192568217747572}
===================

American Association of Blood Banks' (AABB) recommendations^[@bibr16-2192568217747572]^:Recommendation 1: The AABB recommends a restrictive red blood cell (RBC) transfusion threshold in which the transfusion is not indicated until the hemoglobin level is 7 g/dL for hospitalized adult patients who are hemodynamically stable, including critically ill patients, rather than a liberal threshold when the hemoglobin level is 10 g/dL (strong recommendation, moderate quality evidence). For patients undergoing orthopedic surgery or cardiac surgery and those with preexisting cardiovascular disease, the AABB recommends a restrictive RBC transfusion threshold (hemoglobin level of 8 g/dL; strong recommendation, moderate quality evidence). The restrictive hemoglobin transfusion threshold of 7 g/dL is likely comparable to 8 g/dL, but randomized controlled trial (RCT) evidence is not available for all patient categories. These recommendations apply to all but the following conditions for which the evidence is insufficient for any recommendation: acute coronary syndrome, severe thrombocytopenia (patients treated for hematological or oncological disorders who at risk of bleeding), and chronic transfusion--dependent anemia.Recommendation 2: The AABB recommends that patients, including neonates, should receive RBC units selected at any point within their licensed dating period (standard issue) rather than limiting patients to transfusion of only fresh (storage length: \<10 days) RBC units (strong recommendation, moderate quality evidence).

Discussion {#section21-2192568217747572}
==========

We herein conducted a systematic review examining (*a*) whether allogeneic blood transfusion increases the risk of postoperative infection compared with no blood transfusion and (*b*) whether there are any factors that modify the risk of infection associated with allogeneic blood transfusion.

Addressing the first question, a body of very low strength evidence showed mixed results for an association between allogeneic blood transfusion and surgical site infection. This may be a result of confounding factors that are inherent to these different subgroups of patients, factors controlled for in some studies but not others. For example, 3 studies reporting no significant association controlled for American Society of Anesthesiologists (ASA) class^[@bibr12-2192568217747572][@bibr13-2192568217747572]--[@bibr14-2192568217747572]^ while 2 studies reporting a significant association did not.^[@bibr7-2192568217747572],[@bibr8-2192568217747572]^ The posterior approach has been shown to be a risk factor for postoperative infection.^[@bibr17-2192568217747572]^ Three studies in our review adjusted for approach^[@bibr7-2192568217747572],[@bibr12-2192568217747572],[@bibr14-2192568217747572]^ whereas others did not.^[@bibr5-2192568217747572],[@bibr8-2192568217747572],[@bibr10-2192568217747572],[@bibr13-2192568217747572],[@bibr15-2192568217747572]^

Two low-strength studies found a significant association between allogeneic blood transfusion and UTI, yet no association was found between allogeneic blood transfusion and RTI.^[@bibr7-2192568217747572],[@bibr8-2192568217747572]^ The risk of any infection was significantly associated with allogeneic blood transfusions, but again with a very low strength of evidence.^[@bibr6-2192568217747572],[@bibr7-2192568217747572]^ The significant association between all infections and allogeneic blood transfusions found by Fisahn et al^[@bibr6-2192568217747572]^ was in a study population of only 56 patients, the smallest population to yield significant results in our series. When examining individual infection risks (eg, SSI, UTI) the association lost significance. However, the underlying assumption of the current clinical question is that allogeneic blood increases infection risk because of its systemic immunomodulatory effects. It is therefore appropriate to be pooling all postoperative infections to examine for an association with perioperative allogeneic transfusion.

Addressing the second question, a stratification of SSI data by spine segment, lumbar and thoracic, found allogeneic blood transfusion to be significantly associated with SSI in 3 of 4 studies in surgeries restricted to the lumbar spine. The increased potential for infection in the lumbar region may be due to its proximity to the perineal region, a significant potential source of infection.

Limitations {#section22-2192568217747572}
-----------

Studies included consisted only of low-quality retrospective studies with high or moderately high risk of bias. These studies are subject to confounding variables. In this review, every study reporting both univariate and multivariate analyses had important confounds as demonstrated by the large change in the odds ratio between the 2 analyses. Because of the retrospective designs, not all studies collected the same prognostic characteristics and potentially important information was omitted, such as volume of blood transfused. Prospective studies are needed, which identify and control for all important potential confounders for infection.

We estimate that 2400 patients will be needed in a prospective observational study to establish the relationship between autologous blood transfusions and the risk of SSI assuming an SSI risk of 2% in patients without transfusion, a power of 80%, and an effect size of 2.0.

Conclusion {#section23-2192568217747572}
==========

This systematic review failed to find a consistent association between allogeneic transfusion and SSI in patients undergoing spinal surgery. However, the studies were all retrospective with a high or moderately high risk of bias. To understand the nature of the association between allogeneic blood transfusion and subsequent infection in spine surgery, appropriately designed and controlled prospective studies of sufficient power (n = 2400) are required.
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